Dakshidin Corporation, Inc.
DKSC
Other OTC0.00
USD
- -
- -
Dakshidin Corporation, Inc.
DKSC
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Dakshidin Corporation, Inc., operating through its subsidiaries like Whitechapel Holdings, focuses on delivering health and wellness solutions to the market. The company develops and distributes a range of proprietary products, including CBD items, nutraceuticals, and pet supplements, alongside natural extract-based solutions and seaweed-derived offerings. Dakshidin manages its sales through online platforms and diverse distribution networks, encompassing retail, reseller, and direct-to-consumer channels. The firm actively engages in strategic alliances, such as a partnership with GenBio Inc. for anti-inflammatory drugs derived from natural extracts, and collaborates with entities like Cicero Media Group to enhance its market reach. Dakshidin Corporation, Inc. was established in February 2007, having previously operated as Avrada, Inc., and maintains its operational base in Miami, Florida, with additional facilities in Las Vegas, Nevada.
Dakshidin Corporation Marks Strategic Milestone with Stenergy LLC's IP Acquisition and COO Appointment
Whitechapel Announces Its Webinar Series - “Webinars for Living”
Dakshidin Corporation (OTC: DKSC) Relaunches Updated Whitechapelholdingsusa.com & Laughingfrogs.com Websites
Dakshidin CEO Joins GenBio CEO on Podcast to Discuss Entering 191 Billion Dollar Anti-Inflammatory Market, Their Strategic Partnership and Research Potential
Dakshidin Corporation Signs Business Development Deal With Cicero Media Group